First Trust Advisors LP Acquires 9,819 Shares of Abrdn Healthcare Investors (NYSE:HQH)

First Trust Advisors LP increased its holdings in Abrdn Healthcare Investors (NYSE:HQH) by 5.8% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 177,740 shares of the financial services provider’s stock after buying an additional 9,819 shares during the quarter. First Trust Advisors LP’s holdings in Abrdn Healthcare Investors were worth $2,853,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of HQH. Millstone Evans Group LLC bought a new stake in shares of Abrdn Healthcare Investors in the fourth quarter worth approximately $29,000. Brown Brothers Harriman & Co. purchased a new stake in Abrdn Healthcare Investors in the fourth quarter worth approximately $48,000. FNY Investment Advisers LLC bought a new stake in Abrdn Healthcare Investors in the 4th quarter worth approximately $48,000. Wealthfront Advisers LLC purchased a new stake in Abrdn Healthcare Investors during the 4th quarter valued at $118,000. Finally, Stratos Wealth Partners LTD. bought a new position in shares of Abrdn Healthcare Investors during the 4th quarter valued at $187,000. Hedge funds and other institutional investors own 32.60% of the company’s stock.

Abrdn Healthcare Investors Stock Performance

HQH stock opened at $16.28 on Friday. Abrdn Healthcare Investors has a 1 year low of $13.77 and a 1 year high of $19.79. The stock’s fifty day moving average price is $16.01 and its 200-day moving average price is $16.98.

Abrdn Healthcare Investors Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Friday, February 21st were paid a dividend of $0.57 per share. The ex-dividend date was Friday, February 21st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 14.00%.

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.